David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Darden Restaurants
DRI
$25.6B
| $18.2M | 0.02% |
149,596
-243,504
| -62% | -$26.7M |
|
752
PUT
Arista Networks
ANET
$237B
| $18.1M | 0.02% |
920,000
-371,200
| -29% | -$5.89M |
|
753
Newmont
NEM
$139B
| $18.1M | 0.02% |
505,335
+284,157
| +128% | +$9.63M |
|
754
Cisco
CSCO
$434B
| $18.1M | 0.02% |
334,512
-205,054
| -38% | -$9.96M |
|
755
PUT
RTX Corp
RTX
$282B
| $18M | 0.02% |
222,460
+143,010
| +180% | +$10.9M |
|
|
ATSG
756
DELISTED
Air Transport Services Group
ATSG
| $18M | 0.02% |
782,886
-136,886
| -15% | -$3.15M |
|
757
Dell
DELL
$280B
| $17.9M | 0.02% |
601,771
-886,613
| -60% | -$23.4M |
|
758
PUT
Walmart Inc
WMT
$847B
| $17.8M | 0.02% |
549,000
-553,200
| -50% | -$17.9M |
|
759
CALL
Intuit
INTU
$101B
| $17.8M | 0.02% |
68,200
+48,200
| +241% | +$11.1M |
|
760
Ziff Davis
ZD
$1.91B
| $17.7M | 0.02% |
234,996
-120,372
| -34% | -$8.31M |
|
761
Comscore
SCOR
$73.6M
| $17.7M | 0.02% |
43,618
+140
| +0.3% | +$56.9K |
|
762
PUT
Universal Display
OLED
$3.89B
| $17.6M | 0.02% |
115,300
-27,200
| -19% | -$3.37M |
|
763
Southern Company
SO
$104B
| $17.6M | 0.02% |
340,533
-917,121
| -73% | -$45M |
|
764
CALL
Spotify
SPOT
$111B
| $17.6M | 0.02% |
+126,700
| New | +$17.3M |
|
765
PUT
Whirlpool
WHR
$2.62B
| $17.5M | 0.02% |
131,900
-49,100
| -27% | -$6.48M |
|
|
ATH
766
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $17.5M | 0.02% |
428,604
+285,342
| +199% | +$12.2M |
|
|
INFO
767
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $17.4M | 0.02% |
320,330
+291,574
| +1,014% | +$15.3M |
|
768
PUT
3M
MMM
$92.3B
| $17.4M | 0.02% |
100,105
+13,275
| +15% | +$2.23M |
|
769
Alliant Energy
LNT
$17.7B
| $17.3M | 0.02% |
367,790
-503,980
| -58% | -$22.6M |
|
770
CALL
XPO
XPO
$22.5B
| $17.3M | 0.02% |
931,896
+791,085
| +562% | +$15.2M |
|
771
CALL
Texas Instruments
TXN
$236B
| $17.3M | 0.02% |
162,800
+148,800
| +1,063% | +$15.4M |
|
772
Pilgrim's Pride
PPC
$7.57B
| $17.3M | 0.02% |
774,550
+473,608
| +157% | +$9.29M |
|
773
Insmed
INSM
$27.1B
| $17.3M | 0.02% |
593,566
+516,860
| +674% | +$13.4M |
|
774
Carlisle Companies
CSL
$14.4B
| $17.2M | 0.02% |
140,645
+12,659
| +10% | +$1.46M |
|
775
PUT
AB InBev
BUD
$156B
| $17.2M | 0.02% |
205,300
-31,000
| -13% | -$2.38M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.